Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus glimepiride for left ventricular function and cardiac energy metabolism in type 2 diabetes with heart failure
2011-001408-37Phase 4Completed
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Apr 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM) and heart failure (HF) (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Change in myocardial PCr/ATP ratio. Started Apr 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on 2011-001408-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001408-37.